• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Saettele leads WaveLight subsidiary

Article

Sterling, VA-Ralph Saettele will succeed Wade S. Tetsuka as president of U.S. operations for WaveLight Inc.'s U.S. subsidiary.

Sterling, VA-Ralph Saettele will succeed Wade S. Tetsuka as president of U.S. operations for WaveLight Inc.'s U.S. subsidiary.

Saettele had been assistant to the chief executive officer, Max Reindl, and has been responsible for business development in the company's ophthalmology division. The German company established a foot-hold in the U.S. market 3 years ago, and has witnessed "significant growth."

Related Videos
© 2024 MJH Life Sciences

All rights reserved.